Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MRVI · NASDAQ · Pharmaceutical Preparations
$6.98−0.21 (−2.92%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Maravai Lifesciences Holdings (MRVI) · oqro.io/stocks/MRVI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Systematic Financial Management LP disclosed an increased position in MRVI for Q4 2024SourceInsider trade · Traded Jan 31, 2025 · Filed Jan 31, 2025
Officer sold ~$126K of MRVI shares in the open marketSourceInsider trade · Traded Nov 12, 2024 · Filed Nov 14, 2024
Director purchased ~$101K of MRVI shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Systematic Financial Management LP disclosed an increased position in MRVI for Q3 2024SourceInsider trade · Traded Nov 11, 2024 · Filed Nov 12, 2024
Director purchased ~$987K of MRVI shares in the open marketSourcePolitician trade (House) · Transaction Apr 10, 2023 · Disclosed May 19, 2023
Disclosed sale of MRVI — reported range $1,001 - $15,000Source